Zota Health Care's Q1 FY 2026-27 Quarterly Results

Result Summary

• Zota Health Care Ltd reported a 5.6% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Jun (Q1 FY 2026-27). On a year-on-year (YoY) basis, it witnessed a growth of 68.2%.
• Its expenses for the quarter were up by 17.4% QoQ and 86.6% YoY.
• The net profit increased 203.9% QoQ and increased 218.9% YoY.
• The earnings per share (EPS) of Zota Health Care Ltd declined at 12.58 during Q1 FY 2026-27.

Financial Statments for Q1 FY 2026-27

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Zota Health Care Ltd is a company that primarily operates in the pharmaceutical industry. It is known for its diverse range of healthcare products, including pharmaceutical formulations, nutraceuticals, and over-the-counter products. The company has been focused on expanding its product portfolio and increasing its market presence both domestically and internationally. As of the latest available data, there may not be significant recent developments publicly disclosed, but the company continues to operate in a competitive industry characterized by innovation and regulatory dynamics.

Revenue

In the first quarter of fiscal year 2027 (Q1FY27), Zota Health Care Ltd reported a total income of ₹175.65 crores. This represents a quarter-over-quarter (QoQ) increase of 5.6% compared to the ₹166.38 crores recorded in the fourth quarter of fiscal year 2026 (Q4FY26), and a substantial year-over-year (YoY) increase of 68.2% from ₹104.46 crores in the first quarter of fiscal year 2026 (Q1FY26). This growth in revenue highlights the company's efforts in bolstering its sales and potentially expanding its market reach. The upward trend in total income over the periods analyzed reflects a positive trajectory in the company's revenue generation capacity.

Profitability

Zota Health Care Ltd reported a loss in its profitability metrics for Q1FY27. The Profit Before Tax (PBT) for the quarter was negative, standing at -₹43.65 crores, which indicates a deterioration compared to the prior quarter's PBT of -₹26.42 crores and the previous year's same quarter's PBT of -₹13.08 crores. This resulted in a QoQ decline of 65.2% and a YoY decline of 233.7% in profitability before tax. The Profit After Tax (PAT) was also negative at -₹43.95 crores in Q1FY27, compared to -₹14.46 crores in Q4FY26 and -₹13.78 crores in Q1FY26, marking a QoQ change of 203.9% and a YoY change of 218.9%. Earnings Per Share (EPS) similarly declined to -₹12.58, compared to -₹4.13 in Q4FY26 and -₹4.56 in Q1FY26, reflecting changes of 204.6% QoQ and 175.9% YoY.

Operating Metrics

The total expenses for Zota Health Care Ltd in Q1FY27 were ₹219.30 crores, showing a significant increase from the previous quarter's expenses of ₹186.80 crores, resulting in a QoQ increase of 17.4%. Compared to Q1FY26 expenses of ₹117.55 crores, there was a notable YoY increase of 86.6%. The tax expense for Q1FY27 was ₹0.29 crores, which contrasts with the tax rebate recorded in Q4FY26 of -₹11.96 crores and a tax of ₹0.69 crores in Q1FY26, leading to a QoQ change of -102.4% and a YoY change of -58.0%. These metrics indicate changes in the cost structure and tax liabilities of the company over the analyzed periods.